Engineered nanomaterial captures off-target cancer drug to prevent tissue damage

Standard chemotherapies may efficiently kill cancer cells, but they also pose significant risks to healthy cells, resulting in secondary illness and a diminished quality of life for patients. To prevent the previously unavoidable damage, researchers, led by Penn State, have developed a new class of nanomaterials engineered to capture chemotherapy drugs before they interact with healthy tissue.


Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *